Scisparc Ltd (SPRC) Return on Assets ROA from the fourth quarter of 2025 to fourth quarter of 2023 and for the year 2025, Average High and Low, Fundamental Ratios from Dec 31 2025 to Dec 31 2023 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Scisparc Ltd  (NASDAQ: SPRC)


Scisparc Ltd's ROA from the fourth quarter of 2025 to the fourth quarter of 2023 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Scisparc Ltd's ROA in the fourth quarter of 2025?
Scisparc Ltd achieved a return on average assets (ROA) of 179.45 % in its fourth quarter of 2025, this is above SPRC's average return on assets of -48.83%.
Scisparc Ltd assets over the 12 months ending in its fourth quarter of 2025 are valued at $7 million

ROA has improved compared to 99.78% in the third quarter of 2025, due to net income growth.

However, within the Healthcare sector 5 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the third quarter of 2025 from to 34.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Dec 31 2025)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Dec 31 2023)
IV. Quarter
Y / Y Total Assets Change 138.11 % 102.44 % -64.24 % -20.21 % -76.96 %
Y / Y Net Income Change 113.56 % - - - 126.97 %
Net Income (TTM) in million 13 6 6 6 6
Return On Assets (TTM) 179.45 % 99.78 % 119.29 % 81.26 % 76.18 %
SPRC's Total Ranking # 34 # # # # 5040
Total Assets (TTM) in million 8 8 5 8 3
Seq. Total Assets Change 0 % 48.32 % -32.58 % 138.11 % -14.98 %
Seq. Net Income Change - - - - -

SPRC's 5 Years Annual ROA >> Back to SPRC Management Effectiveness >> Compare SPRC ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 2
Sector # 6
Overall # 30

Return On Assets Statistics
High Average Low
196.25 %
-48.83 %
-406.07 %
(Dec 31 2018)   (Dec 31 2019)





Financial Statements
Scisparc Ltd's Assets $ 8 million SPRC's Balance sheet
Scisparc Ltd's Income $ 13 million Quarterly SPRC's Income Statement
SPRC's Income by Division See SPRC's Income by Division



Annual Return On Assets (Dec 31 2025)
FY 2025		 (Dec 31 2024)
FY 2024		 (Dec 31 2023)
FY 2023		 (Dec 31 2022)
FY 2022		 (Dec 31 2021)
FY 2021
Y / Y Total Assets Change 138.11 % -77.73 % -6.21 % 54.52 % -4.11 %
Total Assets in million 8 3 14 15 10
Y / Y Net Income Change - - - - -
Net Income in million 13 -7 -6 -3 -6
Annual Return On Assets 164.84 % -233.43 % -40.94 % -16.92 % -58.38 %

SPRC's 5 Years Annual ROA >> Back to SPRC Management Effectiveness >> Compare SPRC ROA to its Competitors



Comment on SPRC's ROA in the fiscal year ending 2025
In the fiscal year 2025 ROA improved to 164.84 % compared to prior year, due to annual net income growth of % to $12.56 million, while value of Scisparc Ltd's overall assets grew just by 138.11 % to $7.62 million, compared to $7.62 a year before.


More Return On Assets Ratios
SPRC's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
SPRC's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for SPRC's Competitors
Subscribers only: Roa for Scisparc Ltd's Suppliers
Subscribers only: Return On Assets for SPRC's Customers

You may also want to know
SPRC's Roi SPRC's Inventory Turnover Ratio SPRC's Growth Rates SPRC's Dividend Comparisons
SPRC's Profitability Ratios SPRC's Asset Turnover Ratio SPRC's Dividend Growth
SPRC's Roe SPRC's Valuation Ratios SPRC's Financial Strength Ratios SPRC's Dividend Payout Ratio



Companies with similar Return On Assets at Dec 31 2025, within Healthcare Sector ROA
Heartflow Inc   260.21 %
Glucotrack Inc   215.72 %
Oncotelic Therapeutics Inc   209.88 %
Omada Health Inc   166.71 %
Scisparc Ltd  164.84 %
Silexion Therapeutics Corp  144.68 %
Interpace Biosciences Inc   135.21 %
Elutia Inc   129.48 %
Rigel Pharmaceuticals Inc  128.91 %
Capforce Inc   127.99 %
Kyntra Bio Inc   122.33 %
Icecure Medical Ltd  108.42 %
Atara Biotherapeutics Inc   87.55 %
Traws Pharma inc   86.12 %
Sanuwave Health Inc   65.98 %
Exelixis Inc   61.66 %
Entera Bio Ltd   61.28 %
Biocryst Pharmaceuticals Inc   55.61 %
Check Cap Ltd  55.30 %
Advanced Biomed Inc.  53.63 %
Enlivex Therapeutics Ltd  53.10 %
Tg Therapeutics Inc   51.88 %
Aurinia Pharmaceuticals Inc   50.24 %
Pulmatrix Inc   48.84 %
Earth Science Tech Inc   45.81 %
Q32 Bio Inc   45.06 %
Coherus Oncology inc   42.39 %
Elite Pharmaceuticals Inc   41.21 %
Alpha Tau Medical Ltd  40.35 %
Galmed Pharmaceuticals Ltd   37.04 %

Date modified: 2026-07-07T13:49:59+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.